Introduction {#sec1-1}
============

Reflux or gastroesophageal reflux disease (GERD) is one of the common gastrointestinal disorders, with many risk factors such as diabetes and hypertension \[[@ref1]\]. This disorder is present in 16% of the general population and can be associated with common clinical symptoms, such as heartburn and chest pain \[[@ref2]\]. However, clinical symptoms in GERD patients are not limited to gastrointestinal symptoms and can also be manifested as non-gastro-intestinal symptoms, including respiratory disorders, sleep disturbances, and atorvastinuratory symptoms \[[@ref3]\]. The disease causes a 2.5-hour absence from the workplace, a 23 per cent reduction in efficiency, and a 30 per cent reduction in the normal performance of the individual. In general, there is a significant reduction in the quality of life in patients suffering from GERD \[[@ref4]\]. It also imposes huge costs on individuals and health systems \[[@ref5]\]. Therefore, treatment for GERD patients is important for improving their quality of life. Treatment in this area is divided into two categories of therapeutic and surgical treatments, both of which not only reduce the severity of the symptoms of the patients but also significantly improve their quality of life \[[@ref6]\] \[[@ref7]\]. It is worth noting that, in both short and long-term, the effectiveness of surgical treatments is far more than pharmaceutical treatments, and drug therapies are particularly effective on clinical symptoms such as dysphagia \[[@ref6]\]\[[@ref8]\]. However, 40% of patients do not show any proper therapeutic response, and they refer to refractory GERD, which requires the adoption of other therapies \[[@ref9]\]. The causes of GERD Refractory include Acid Reflux, Non-Acid Reflux, Esophageal Hypersensitivity, and Functional Heart Burn \[[@ref10]\]. Moreover, only a few studies have been done in Iranian patients \[[@ref11]\] \[[@ref12]\] \[[@ref13]\].

On the other hand, GERD is a long-term condition in which stomach contents enter the oesophagus and cause symptoms or complications. Complications include esophagitis, oesophagal strictures, and Barrett's oesophagus. There are some risk factors involved in the disease, including obesity, pregnancy, smoking, hiatus hernia, and taking some special medications. Drugs that affect gastric reflux are described to be as follow: antihistamines, calcium channel blockers, antidepressants and sleep medications. Diagnosis among people who do not respond in simple ways may be made in other ways, such as gastroscopy, oesophagal pH monitoring, and or impedance-pH monitoring \[[@ref13]\] \[[@ref14]\] \[[@ref15]\] \[[@ref16]\].

Therefore, the goal of this study was to evaluate the causes of refractory GERD in patients who referred to Taleghani Hospital from 2009 to 2017 as off- proton pump inhibitor (off-PPI).

Methods {#sec1-2}
=======

This study was conducted by a descriptive cross-sectional study of off-PPI. A total of 572 patients with refractory GERD who referred to Tehran Taleghani Hospital from 2009 to 2017 were evaluated. Endoscopy results and response to medical treatment were controlled as interventional factors. In the manometer, the absence of motion disorders, such as achalasia and diffuse oesophagal spasm (DES), was confirmed.

The required data were extracted from patients' files, including the age, sex, duration of GERD symptoms, pH and Impedance parameters, and symptom association probability (SAP), as well as proximal extension and bolus clearance time (BCT). Then, the prevalence of different parameters of the 24h PH Impedance was extracted from them using file contents. Finally, data analysis was performed using SPSS software version 24. The mean and standard deviations were used to evaluate quantitative variables, where qualitative variables were presented as absolute and relative frequency. The tests used in this field included chi-square and analysis of variance. The significance level for the relationships between variables was considered 0.5.

Inclusion criteria {#sec2-1}
------------------

Failure of medical treatment with protein pumps inhibitors (PPIs) for at least one month, once or twice daily \[[@ref12]\].

Exclusion criteria {#sec2-2}
------------------

1\. Patients who had anti-reflux surgery, either PPI or H2-blocker.

2\. Patients with atypical GERD symptoms.

3\. Motion disorders, such as achalasia and diffuse oesophagal spasm.

4\. Non-Iranian patients.

5\. Patients with abnormal manometry.

6\. Age younger than 18 or over 80 years old. 7. Systemic disease.

Results {#sec1-3}
=======

In this study, 572 subjects were studied. Their mean age was 38.2 years (range 18-80 years), and mean duration of clinical symptoms was 5.1 years (from 1 to 16 years). Also, 48.3% were males, and 51.7% were females. DeMeester Score was abnormal in 44.2% of patients and Total Reflux Time in 45.5% of patients. The frequency of reflux and the frequency of long-term reflux was 40% and 24.1%, respectively. In 2.6% of patients, BCT was abnormal and proximal extension was observed in 41.8% of subjects. Attenuation correction (AC) findings in the upright and supine positions were attributed to frequencies of 20.5% and 25.2%, respectively. Weakly Acid (WA) findings in the upright and supine positions were abnormal in 50.9% and 49.5% respectively. Abnormal Non-Acid (NA) findings in the upright and supine positions were observed at 6.3 and 3.3 per cent. Mixed findings were abnormal in 61.9% and 65.4%, based on the upright and supine positions ([Table 1](#T1){ref-type="table"}).

###### 

Frequency distribution of data based on various findings in patients

                                  Count   Layer N%
  -------------------- ---------- ------- ----------
  DeMeester Score      Abnormal   253     44.2%
  Total Reflux time    Abnormal   260     45.5%
  Number of Reflux     Abnormal   229     40%
  Number of Long       Abnormal   138     24.1%
  Longest Reflux       Abnormal   242     42.3%
  BCT                  Abnormal   15      2.6%
  Proximal Extension   Pos        239     41.8%
  Upright AC           Abnormal   117     20.5%
  Supine AC            Abnormal   144     25.2%
  Upright WA           Abnormal   291     50.9%
  Supine WA            Abnormal   283     49.5%
  Upright NA           Abnormal   36      6.3%
  Supine NA            Abnormal   19      3.3%
  Upright Mixed        Abnormal   354     61.9%
  Supine Mixed         Abnormal   374     65.4%

SAP findings were related to the symptoms of the patient in 55.8% of the patients, while 30.2% of the patients had SAP findings without any association with the symptoms of the patient. They were also Results in 7% of cases were Pure Acid Reflux followed by Weakly Acid (1%), Non-Acid (0.3%), Mixed & Gas (5.2%), Functional (58.4%) and Esophageal Hypersensitivity (28%). Furthermore, Weakly Acid plus Acid was also found to be 8%, and Weakly Acid + Acid + Non-Acid were determined as 8.3% ([Table 2](#T2){ref-type="table"}).

###### 

Frequency of diagnosis in patients

                                        Frequency   Per cent
  ------- ----------------------------- ----------- ----------
  Valid   Pure Acid Reflux              40          7
          Weakly Acid                   6           1
          Non-Acid                      2           0.3
          Mixed&Gas                     30          5.2
          Functional                    334         58.4
          Oesophagal Hypersensitivity   160         28
          Total                         572         100

Analysis of variance (ANOVA) did not show a significant difference in the frequency distribution of diagnosis based on the age of the patients (P = 0.216). The frequency distribution of diagnosis did not show a significant statistical relationship regarding gender-based on chi-square test (P = 0.721). The prevalence of functional conditions in men and women was revealed to be 59.1 and 57.6%, respectively while the cases of hypersensitivity were reported in 27.4% of men and 28.6% of women ([Table 3](#T3){ref-type="table"}).

###### 

Distribution of diagnosis based on gender

                    Diagnosis   Total                                                        
  -------- -------- ----------- ---------- ---------- ----------- ------------- ------------ ------------
  Gender   Female   19 (6.9%)   2 (0.7%)   2 (0.7%)   15 (5.4%)   159 (57.6%)   79 (28.6%)   276 (100%)
           Male     21 (7.1%)   4 (1.4%)   0          15 (5.1%)   175 (59.1%)   81 (27.4%)   296 (100%)
  Total             40 (7%)     6 (1%)     2 (0.3%)   30 (5.2%)   334 (58.4%)   160 (28%)    572 (100%)

The frequency of diagnosis showed that the duration of symptoms was not statistically significant (P = 0.429) based on the ANOVA test.

Discussion {#sec1-4}
==========

In this study, we investigated the various causes of GERD refractory in patients who were referred to Taleghani patient in Tehran from 2009 to 2017. All subjects in this study were Off PPI, meaning that patients did not take PPI and anti-acid for 2 weeks before testing. The test results showed that 7% of the cases belonged to Pure Acid Reflux based on 24 h pH-impedance, followed by Weakly Acid (1%), Non-Acid (0.3%), Mixed & Gas (5.2%), Functional (58.4%) and Esophageal Hypersensitivity (28%). Also, Weakly Acid + Acid + Non-Acid cases were found to be 8.3%, where is the most common cause of refractory cases followed by hypersensitivity, which is consistent with other studies in this area \[[@ref17]\]. These results are consistent with other studies in this area \[[@ref17]\]. Penagini et al., (2015) evaluated 50 patients with refractory GERD in Italy. They determined that 15 of the patients (30%) had functional heartburn \[[@ref18]\], while this rate was about 2 times higher in our research. In a cross-sectional study, Frazzoni et al., examined 80 patients with refractory GERD, 35% of them had functional heartburn \[[@ref19]\], which was lower than the result of our study. In another study, Savarino et al. performed an analytical cross-sectional study in Italy with 219 patients suffering from refractory GERD that 39% had functional heartburn \[[@ref20]\]. In the present study, this was higher which could be due to the 3-fold sample size.

Jung et al., (2007) in the United States, assessed 2298 patients with refractory GERD and found that 3% of men and 4% of women had suffered from functional disorders such as functional heartburn \[[@ref21]\]. The results of the study are in agreement with the results of the current study. In another study by Savarino et al., 2009 found that 27% of patients with refractory GERD suffered from functional heartburn \[[@ref22]\], which was half the amount, obtained in our study. The higher number of the present study can be because of the examination centre as a referral hospital. A cross-sectional study by Mohammed Khan et al. in 2014 found that almost 60% of patients with refractory PPIs NERD and SAP (+) had no acid reflux, and about half of nonerosive gastroesophageal reflux disease (NERD) patients on PPI had normal multichannel intraluminal impedance-pH (MII-pH) monitoring, which was equally divided into two groups: Functional Heart Burn and hyper-sensitive esophagus \[[@ref23]\]. We did not find this equal ratio in our study, and the frequency of functional cases was higher. Herregods et al., reported in an analytical cross-sectional report that roughly one-third of patients referring to GERD symptoms have problems other than reflux, the most common of which is Functional Heart Burn. This justifies why these patients do not benefit from anti-acid therapy \[[@ref24]\], and in our study, this is proven. Moreover, different studies on various subjects have published the regarding the above results \[[@ref25]\] \[[@ref26]\] \[[@ref27]\] \[[@ref28]\] \[[@ref29]\].

In conclusion, our data suggest that more than half of GERD patients in the 24h pH-impedance analysis have functional disorders. Therefore, due to the high incidence of functional and hypersensitivity cases, we can treat the remaining cases according to the prevalence before making expensive and inaccessible tests. Taken together, it is recommended to use a treatment period for functional and hypersensitivity, such as selective serotonin reuptake inhibitors (SSRIs) (fluoxetine, etc.).
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